Effects of a Self-management Program for Temporomandibular Myalgia in Subjects With Fibromyalgia: a Single Arm Study
Launched by JOSE EDGAR FERRANDEZ GOMEZ · Jun 20, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a self-management program can help people with fibromyalgia who also experience pain in their jaw area, known as temporomandibular myalgia. Fibromyalgia causes widespread pain, and many patients (about 80%) have issues with their jaw muscles. The goal of the study is to see if an online program that teaches exercises, self-massage techniques, and provides helpful information can improve pain and overall quality of life for these patients.
To participate, you need to be an adult over 18 years old, have a diagnosis of fibromyalgia, and have experienced jaw pain for at least three months. The study will involve three online sessions where you'll learn about pain management and practice exercises. Researchers will check in with you before the program starts and again four weeks, six months, and twelve months after completing it to see how you’re doing. Importantly, the study does not expect any serious side effects from the program, making it a safe option for those who qualify.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults over 18 years old.
- • Subjects diagnosed with fibromyalgia.
- • Orofacial pain of at least 3 months of evolution (considered chronic, according to IASP).
- • Presence of myalgia, local myalgia, myofascial pain or referred myofascial pain in the temporomandibular region (according to DC/TMD).
- Exclusion Criteria:
- • Internal temporal-romandibular joint disorder with anterior disc displacement, joint pathology (arthritis), facial paralysis (active), mandibular fracture (active), infectious-inflammatory picture of odontogenic origin (active).
- • Pregnancy.
- • Neuropsychiatric pathologies (schizophrenia, bipolarity, cognitive alteration).
- • Subjects receiving any other physiotherapy treatment in the mandibular region.
About Jose Edgar Ferrandez Gomez
Jose Edgar Ferrandez Gomez is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in managing and overseeing clinical studies, he emphasizes rigorous adherence to ethical standards and regulatory compliance. His collaborative approach fosters partnerships with research institutions and healthcare professionals, ensuring that trials are conducted efficiently and effectively. By prioritizing innovation and patient safety, Ferrandez Gomez aims to contribute significantly to the development of new therapies and the enhancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Murcia, , Spain
Murcia, , Spain
Patients applied
Trial Officials
J. Édgar Ferrández-Gómez
Principal Investigator
Universidad de Murcia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials